Thursday, March 30, 2023
CLINICAL ADVANCES IN
Read Overview
Supported by an independent educational grant from
Steering Committee Chair
Professor
University Hospital of Salamanca
Salamanca, Spain
Steering Committee Member
Professor of Medicine
Director of Clinical Research
Multiple Myeloma Program
Icahn School of Medicine at Mount Sinai Hospital
New York, New York, United States
Steering Committee Member
Professor of Haematology & Myeloma Studies, Honorary Consultant Haematologist
Clinical Director CTRU
Section of Experimental Haematology
Leeds Institute of Cancer and Pathology
University of Leeds
Leeds, United Kingdom
Steering Committee Member
Professor
Head of Myeloma Clinic, Department of Haematology
Hospital La Miletrie
Poitiers, France
Steering Committee Member
Associate Professor of Medicine
University of Calgary
Calgary, Canada
Steering Committee Member
Professor of Hematology
Amsterdam University Medical Center
Location VU University Medical Center
Amsterdam, the Netherlands
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Adaptive; Amgen; Bristol Myers Squibb Company; Celgene; GlaxoSmithKline; Janssen; Oncopeptides; Pfizer; Regeneron; Roche; Sanofi; Sea-Gen; Takeda
Served as a speaker or a member of a speakers bureau for: Amgen; Bristol Myers Squibb Company; Celgene; GlaxoSmithKline; Janssen; Oncopeptides; Sanofi
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Amgen; Antengene; Celgene/Bristol Myers Squibb; Genentech; GlaxoSmithKline; Janssen; Karyopharm; Oncopeptides; Sanofi Genzyme; Seattle Genetics; Secura Bio; Shattuck Labs; Takeda
Received grants for clinical research from: Amgen; Celgene; Janssen; Seattle Genetics; Takeda
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen; Janssen; Karyopharm; Oncopeptides; Pfizer; Roche; Sanofi; Takeda
Served as a speaker or a member of a speakers bureau for: Amgen; Janssen; Takeda
Received grants for clinical research from: Takeda
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen; Biologic; Bristol Myers Squibb; Gilead; GlaxoSmithKline; Harpoon Therapeutics; Janssen; Karyopharm; Merck; Novartis; Oncopeptide; Ono Pharmaceutical; Pfizer; Roche; Sanofi; Takeda
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bristol Myers Squibb Company; Janssen
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Adaptive; Amgen; Bayer; Bristol Myers Squibb; Celgene; Janssen Pharmaceuticals; Novartis; Roche; Servier; Takeda
Received grants for clinical research from: Amgen; Bristol Myers Squibb; Celgene; Cellectis; Janssen Pharmaceuticals; Novartis
